Aria CV Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Series C1

  • Latest Deal Amount
  • $3.6M

  • Investors
  • 14

Aria CV General Information

Description

Developer of an implantable cardiovascular device designed to treat pulmonary hypertension. The company's devices reduce the workload on the heart and have the potential to enhance both the survival and quality of life of those suffering from pulmonary hypertension, enabling patients to improve outcomes by reducing the workload on the right side of the heart.

Contact Information

Website
www.ariacv.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2300 Myrtle Avenue
  • Suite 250
  • Saint Paul, MN 55114
  • United States
+1 (651)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Services
Surgical Devices
Vertical(s)
Corporate Office
  • 2300 Myrtle Avenue
  • Suite 250
  • Saint Paul, MN 55114
  • United States
+1 (651)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aria CV Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C1) 18-Aug-2025 $3.6M Completed Generating Revenue
4. Later Stage VC (Series C) 18-Jul-2022 Completed Generating Revenue
3. Accelerator/Incubator 17-Jun-2021 Completed Generating Revenue
2. Later Stage VC (Series B) 25-Feb-2020 $31M $38.8M Completed Clinical Trials - Phase 4
1. Later Stage VC (Series A) 07-Jul-2015 $7.8M $7.8M Completed Clinical Trials - Phase 4
To view Aria CV’s complete valuation and funding history, request access »

Aria CV Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C-1
Series C-4
Series C-3
Series C-2
Series B 33,641,273 $0.001000 $0.06 $0.8 $0.8 1x $0.57 27.57%
Series A 12,341,568 $0.001000 $0.06 $0.75 $0.75 1x $0.54 9.92%
To view Aria CV’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Aria CV Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an implantable cardiovascular device designed to treat pulmonary hypertension. The company's devices reduce
Therapeutic Devices
Saint Paul, MN
19 As of 2024

Clichy, France
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aria CV Competitors (17)

One of Aria CV’s 17 competitors is CorWave, a Venture Capital-Backed company based in Clichy, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CorWave Venture Capital-Backed Clichy, France
HighLife Venture Capital-Backed Paris, France
InnovHeart Venture Capital-Backed Milan, Italy
SynCardia Systems Formerly PE-Backed Tucson, AZ
JenaValve Technology Private Equity-Backed Irvine, CA
You’re viewing 5 of 17 competitors. Get the full list »

Aria CV Patents

Aria CV Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4171397-A1 Implantable devices for reducing pulsatile pressure within a blood vessel Active 25-Jun-2020
EP-4171397-B1 Implantable devices for reducing pulsatile pressure within a blood vessel Active 25-Jun-2020
EP-4171397-C0 Implantable devices for reducing pulsatile pressure within a blood vessel Active 25-Jun-2020
US-12427291-B2 Implantable devices for reducing pulsatile pressure within a blood vessel Active 25-Jun-2020
US-20210402159-A1 Implantable devices for reducing pulsatile pressure within a blood vessel Active 25-Jun-2020 A61M25/104
To view Aria CV’s complete patent history, request access »

Aria CV Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aria CV Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
KOFA Healthcare Venture Capital Minority
Gravity Fund Venture Capital Minority
Samothrace Partners Angel Group Minority
MedTech Innovator Accelerator/Incubator Minority
Angel Physicians Fund Angel Group Minority
You’re viewing 5 of 14 investors. Get the full list »

Aria CV FAQs

  • When was Aria CV founded?

    Aria CV was founded in 2010.

  • Where is Aria CV headquartered?

    Aria CV is headquartered in Saint Paul, MN.

  • What is the size of Aria CV?

    Aria CV has 19 total employees.

  • What industry is Aria CV in?

    Aria CV’s primary industry is Therapeutic Devices.

  • Is Aria CV a private or public company?

    Aria CV is a Private company.

  • What is the current valuation of Aria CV?

    The current valuation of Aria CV is .

  • What is Aria CV’s current revenue?

    The current revenue for Aria CV is .

  • How much funding has Aria CV raised over time?

    Aria CV has raised $50.2M.

  • Who are Aria CV’s investors?

    KOFA Healthcare, Gravity Fund, Samothrace Partners, MedTech Innovator, and Angel Physicians Fund are 5 of 14 investors who have invested in Aria CV.

  • Who are Aria CV’s competitors?

    CorWave, HighLife, InnovHeart, SynCardia Systems, and JenaValve Technology are some of the 17 competitors of Aria CV.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process